Reimbursement

In most healthcare systems, the question of who pays decides whether a product succeeds. Even the most innovative device, diagnostic or therapy will struggle if hospitals, physicians or patients cannot obtain adequate reimbursement. Stuart-Houghton Associates helps medical technology, healthcare and investment goods companies understand reimbursement systems and secure fair, sustainable payment.

A complex landscape

Rules differ widely between countries and settings. Mistakes or delays can cost months or years of revenue.

Our services

• Landscape analysis – how products like yours are funded in your target markets.
• Coding and tariff analysis – existing codes and payment mechanisms that may apply.
• Gap analysis – whether current reimbursement is adequate or new codes are needed.
• Reimbursement strategy – the most realistic route to coverage in each market.
• Evidence requirements – the clinical and economic data payers expect.
• Application support – submissions, arguments and documentation.
• Customer support materials – guides that help hospitals and practices bill correctly.

Start early, think integrated

Decisions made during development and study design determine what evidence you will have later. Planning reimbursement early avoids costly additional studies and shortens time to coverage. Because reimbursement is closely tied to pricing and market access, we address them together and translate clinical or economic evidence into clear arguments for payers.

Our work rests on thorough research into official catalogues, tariff systems and assessment decisions, presented in structured, easy-to-use formats.